Cutler Group’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,900
Closed -$19K 1759
2023
Q4
$19K Hold
1,900
﹤0.01% 863
2023
Q3
$19K Buy
+1,900
New +$19K ﹤0.01% 893
2023
Q1
Sell
-16,395
Closed -$149K 2172
2022
Q4
$149K Sell
16,395
-14,472
-47% -$132K 0.01% 519
2022
Q3
$249K Sell
30,867
-6,806
-18% -$54.9K 0.02% 430
2022
Q2
$283K Buy
37,673
+5,016
+15% +$37.7K 0.02% 370
2022
Q1
$306K Buy
32,657
+27,957
+595% +$262K 0.02% 470
2021
Q4
$37K Buy
+4,700
New +$37K ﹤0.01% 1286
2021
Q3
Hold
0
2701
2021
Q2
Hold
0
2695
2021
Q1
Sell
-14,900
Closed -$143K 2634
2020
Q4
$143K Sell
14,900
-3,728
-20% -$35.8K 0.01% 668
2020
Q3
$167K Hold
18,628
0.01% 530
2020
Q2
$229K Sell
18,628
-4,800
-20% -$59K 0.02% 414
2020
Q1
$210K Buy
23,428
+7,712
+49% +$69.1K 0.01% 410
2019
Q4
$154K Buy
15,716
+5,900
+60% +$57.8K 0.01% 578
2019
Q3
$67K Sell
9,816
-4,434
-31% -$30.3K 0.01% 719
2019
Q2
$131K Buy
14,250
+14,116
+10,534% +$130K 0.01% 610
2019
Q1
$2K Sell
134
-3,100
-96% -$46.3K ﹤0.01% 1382
2018
Q4
$49K Hold
3,234
﹤0.01% 838
2018
Q3
$69K Buy
3,234
+600
+23% +$12.8K ﹤0.01% 848
2018
Q2
$64K Sell
2,634
-3,366
-56% -$81.8K 0.01% 835
2018
Q1
$102K Buy
6,000
+4,566
+318% +$77.6K 0.01% 725
2017
Q4
$27K Sell
1,434
-37,474
-96% -$706K ﹤0.01% 1302
2017
Q3
$684K Sell
38,908
-56,989
-59% -$1M 0.03% 349
2017
Q2
$3.19M Sell
95,897
-48,986
-34% -$1.63M 0.12% 112
2017
Q1
$4.65M Buy
144,883
+107,779
+290% +$3.46M 0.19% 85
2016
Q4
$1.35M Buy
37,104
+21,518
+138% +$780K 0.05% 228
2016
Q3
$717K Buy
15,586
+13,574
+675% +$624K 0.03% 303
2016
Q2
$101K Buy
2,012
+1,551
+336% +$77.9K 0.01% 1015
2016
Q1
$24K Buy
461
+161
+54% +$8.38K ﹤0.01% 1649
2015
Q4
$19K Buy
+300
New +$19K ﹤0.01% 1892